DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $636,540 | -10.5% | 41,200 | -5.1% | 0.00% | 0.0% |
Q4 2022 | $711,326 | -17.1% | 43,400 | -10.9% | 0.00% | 0.0% |
Q3 2022 | $858,000 | +540.3% | 48,700 | +377.5% | 0.00% | – |
Q2 2022 | $134,000 | -73.2% | 10,200 | -30.6% | 0.00% | -100.0% |
Q3 2021 | $500,000 | +11.6% | 14,707 | 0.0% | 0.00% | – |
Q2 2021 | $448,000 | -60.0% | 14,707 | -41.1% | 0.00% | -100.0% |
Q1 2021 | $1,120,000 | -10.5% | 24,982 | +14.0% | 0.00% | -50.0% |
Q4 2020 | $1,251,000 | +11.3% | 21,919 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,124,000 | -41.8% | 21,919 | -32.2% | 0.00% | -33.3% |
Q2 2020 | $1,930,000 | +57.7% | 32,319 | +8.7% | 0.00% | +50.0% |
Q1 2020 | $1,224,000 | -38.6% | 29,719 | -7.2% | 0.00% | -33.3% |
Q4 2019 | $1,993,000 | +443.1% | 32,019 | +196.0% | 0.00% | +200.0% |
Q3 2019 | $367,000 | – | 10,819 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |